These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32345553)

  • 1. Comparison of Fetal Fibronectin and Phosphorylated Insulin-Like Growth Factor Binding Protein-1 Testing to Predict Preterm Delivery in Symptomatic Women: A 10-Year Retrospective Study.
    Chen MX; Dansereau J; Hoag GN
    J Obstet Gynaecol Can; 2020 Aug; 42(8):971-976. PubMed ID: 32345553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of rapid phIGFBP-I assay for predicting preterm labor in symptomatic patients.
    Cooper S; Lange I; Wood S; Tang S; Miller L; Ross S
    J Perinatol; 2012 Jun; 32(6):460-5. PubMed ID: 21997470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of rapid bedside tests for phosphorylated insulin-like growth factor-binding protein 1 and fetal fibronectin to predict preterm birth.
    Tripathi R; Tyagi S; Mala YM; Singh N; Pandey NB; Yadav P
    Int J Gynaecol Obstet; 2016 Oct; 135(1):47-50. PubMed ID: 27388033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined insulin-like growth factor binding protein-1/interleukin-6 (Premaquick) versus fetal fibronectin for predicting preterm delivery among women with preterm contractions.
    Asiegbu AC; Eleje GU; Ibeneme EM; Onyegbule OA; Chukwu LC; Egwim AV; Okonko CO; Eze SC; Eke AC
    Int J Gynaecol Obstet; 2020 May; 149(2):171-177. PubMed ID: 32090329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin.
    Riboni F; Vitulo A; Dell'avanzo M; Plebani M; Battagliarin G; Paternoster D
    Arch Gynecol Obstet; 2011 Dec; 284(6):1325-9. PubMed ID: 21274721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New rapid bed-side test to predict preterm delivery: phosphorylated insulin-like growth factor binding protein-1 in cervical secretions.
    Lembet A; Eroglu D; Ergin T; Kuscu E; Zeyneloglu H; Batioglu S; Haberal A
    Acta Obstet Gynecol Scand; 2002 Aug; 81(8):706-12. PubMed ID: 12174153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of preterm delivery among women with threatened preterm labor.
    Eroglu D; Yanik F; Oktem M; Zeyneloglu HB; Kuscu E
    Gynecol Obstet Invest; 2007; 64(2):109-16. PubMed ID: 17339775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour.
    Audibert F; Fortin S; Delvin E; Djemli A; Brunet S; Dubé J; Fraser WD
    J Obstet Gynaecol Can; 2010 Apr; 32(4):307-12. PubMed ID: 20500936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Assessment of Cervical Phosphorylated Insulin-like Growth Factor Binding Protein-1 by Bedside Vaginal Swab Test Really Predict Preterm Birth?
    Tenoudji-Cohen Couka L; Donato XC; Glowaczower E; Squercioni-Aumont A; Katsogiannou M; Desbriere R
    Reprod Sci; 2021 Jul; 28(7):2006-2011. PubMed ID: 33405213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
    Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical phosphorylated insulin-like growth factor binding protein-1 test for the prediction of preterm birth: a systematic review and metaanalysis.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2016 Jan; 214(1):57-73. PubMed ID: 26149828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
    Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME
    Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of spontaneous preterm delivery in women presenting with premature labor: a comparison of placenta alpha microglobulin-1, phosphorylated insulin-like growth factor binding protein-1, and cervical length.
    Nikolova T; Uotila J; Nikolova N; Bolotskikh VM; Borisova VY; Di Renzo GC
    Am J Obstet Gynecol; 2018 Dec; 219(6):610.e1-610.e9. PubMed ID: 30240653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of fetal fibronectin testing in clinical practice.
    Cornelissen LGH; van Oostrum NHM; van der Woude DAA; Rolf C; Porath MM; Oei SG; van Laar JOEH
    J Obstet Gynaecol Res; 2020 Mar; 46(3):405-412. PubMed ID: 31955485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid cervical phIGFBP-1 test in asymptomatic twin pregnancies: role in mid-pregnancy prediction of spontaneous preterm delivery.
    Fichera A; Prefumo F; Zanardini C; Stagnati V; Frusca T
    Prenat Diagn; 2014 May; 34(5):450-9. PubMed ID: 24436153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.